Delivery Order SPE2DB22D2006-SPE2DB25FW2YX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,681.49 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,533.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 300 mg syringes, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award was issued on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as...
- This delivery order, valued at $2,807.89, was awarded on July 18, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract employs firm fixed-price pricing and is scheduled for completion by July 21, 2025. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. No...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,764.94 on July 23, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes/cartridges. This firm fixed price delivery order, with an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The award was not designated as a set-aside contract and was competitively awarded. Performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes with a ceiling value of $1,382.47. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,731.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,564,248,487 units of Abilify Maintena ER 400 mg syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,714.54 for the supply of Abilify Maintena Extended-Release (ER) 400 mg syringes. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency awarded a $12,158 delivery order to Amerisourcebergen Drug Corporation for 300mg doses of ABILIFY MAINTENA extended release injectable suspension. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from July 25 to July 26, 2023 to supply the pharmaceutical to an unspecified DOD program. As a major pharmaceutical distributor, Amerisourcebergen will deliver the prescribed medication to the Defense Logistics Agency without...
- The Defense Logistics Agency awarded a $4,877 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg doses of ABILIFY MAINTENA extended release injectable suspension. As the prime contractor, Amerisourcebergen will deliver the prescribed antipsychotic medication to a facility located in Conshohocken, Pennsylvania under a one-day period of performance starting August 1st and concluding August 2nd, 2023. No subcontractors or set aside designations were indicated. The...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2YXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, delivers a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency and other federal healthcare systems. The company's delivery orders under the DLA Troop Support Medical IDC demonstrate consistent capability to meet federal procurement requirements through open competition, ranging from small-value transactions to substantial orders. This particular delivery order for Abilify Maintena ER 400 mg—an injectable antipsychotic medication—represents a routine pharmaceutical supply transaction typical of the company's extensive federal contract portfolio serving military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/29/25 |